Phase 2a randomised controlled feasibility trial of a new 'balanced binocular viewing' treatment for unilateral amblyopia in children age 3-8 years: trial protocol. (2022)

First Author: Dahlmann-Noor AH

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-051423

PubMed Identifier: 35613759

Publication URI: http://europepmc.org/abstract/MED/35613759

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 5

ISSN: 2044-6055